3billion is a genetic testing company specialized in rare disease diagnosis.
We provide a comprehensive clinical report based on whole exome sequencing, that adheres to the recommendations of ACMG guidelines.
Using our own variant interpretation software, we made it possible to give results with a higher-than-average diagnostic rate at a reasonable price.
By working with doctors from 75 institutions in 27 countries worldwide, we are improving our diagnostic power and clinical credibility of our service.
For more details of our service and business discussions, please visit 3billion's website.